Financial reports
Current reports
6-K
Skylight Health Provides Clinical Research Update
24 Aug 22
6-K
Skylight Health Announces Closing of Convertible Debenture Financing
17 Aug 22
6-K
Skylight Health Group Reports Second Quarter 2022 Financial Results and Upsizes Financing
15 Aug 22
6-K
Condensed Interim Consolidated Financial Statements
15 Aug 22
6-K
Skylight Health Announces Timing of its Second Quarter 2022 Results Conference Call
10 Aug 22
6-K
Skylight Health Announces Non-Brokered Private Placement of Convertible Debenture Units
8 Aug 22
6-K
Skylight Health Announces Series A Preferred Stock Cash Dividend
20 Jul 22
6-K
Skylight Health Announces Re-Appointment of Co-Founder Kash Qureshi as President
14 Jul 22
6-K
Skylight Health Announces Results of 2022 Annual General & Special Meeting of Shareholders
29 Jun 22
6-K
Skylight Health Announces Appointment of Interim Chief Financial Officer and Corporate Update
24 Jun 22
Registration and prospectus
15-12G/A
Securities registration termination (amended)
1 Sep 22
15-12G
Securities registration termination
31 Aug 22
25
Voluntary exchange delisting
16 Aug 22
SUPPL
Supplemental materials (foreign)
2 Dec 21
8-A12B
Registration of securities on exchange
1 Dec 21
FWP
Free writing prospectus
10 Nov 21
FWP
Free writing prospectus
10 Nov 21
SUPPL
Supplemental materials (foreign)
10 Nov 21
F-10
Registration of securities (Canada)
5 Oct 21
RW
Registration withdrawal request
5 Oct 21
Proxies
No filings